These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 6448576

  • 1. Pharmacokinetics and bacteriological efficacy of moxalactam (LY127935), netilmicin, and ampicillin in experimental gram-negative enteric bacillary meningitis.
    Schaad UB, McCracken GH, Loock CA, Thomas ML.
    Antimicrob Agents Chemother; 1980 Mar; 17(3):406-11. PubMed ID: 6448576
    [Abstract] [Full Text] [Related]

  • 2. Treatment of experimental Haemophilus influenzae type b meningitis with 1-oxa-beta-lactam (LY127935).
    Cordera CS, Pekarek RS.
    Antimicrob Agents Chemother; 1980 Feb; 17(2):258-62. PubMed ID: 6446260
    [Abstract] [Full Text] [Related]

  • 3. Successful moxalactam therapy for gram-negative bacillary meningitis in neonates.
    Ramos OM, Kaplan SL, Mason EO, Denson S, Pickering LK.
    South Med J; 1982 May; 75(5):632-3. PubMed ID: 6210970
    [Abstract] [Full Text] [Related]

  • 4. Moxalactam (LY127935) in treatment of meningitis due to gram-negative bacilli.
    Fisher JF, Carter MJ, Parsons J, Rissing JP.
    Antimicrob Agents Chemother; 1981 Feb; 19(2):218-21. PubMed ID: 6214985
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis.
    Schaad UB, McCracken GH, Loock CA, Thomas ML.
    J Infect Dis; 1981 Feb; 143(2):156-63. PubMed ID: 6260870
    [Abstract] [Full Text] [Related]

  • 6. Successful treatment of gram-negative bacillary meningitis with moxalactam.
    Olson DA, Hoeprich PD, Nolan SM, Goldstein E.
    Ann Intern Med; 1981 Sep; 95(3):302-5. PubMed ID: 6455950
    [Abstract] [Full Text] [Related]

  • 7. Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants.
    Schaad UB, McCracken GH, Threlkeld N, Thomas ML.
    J Pediatr; 1981 Jan; 98(1):129-36. PubMed ID: 6450277
    [Abstract] [Full Text] [Related]

  • 8. Mecillinam alone and in combination with ampicillin or moxalactam in experimental Escherichia coli meningitis.
    Schaad UB, Grimm LM, Beskid G, Cleeland R, Nelson JD, McCracken GH.
    Infection; 1982 Jan; 10(2):90-6. PubMed ID: 6284652
    [Abstract] [Full Text] [Related]

  • 9. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
    Hall WH, Opfer BJ, Gerding DN.
    Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
    [Abstract] [Full Text] [Related]

  • 10. Diffusion of a new beta-lactam (LY 127935) into cerebrospinal fluid. Implications for therapy of gram-negative bacillary meningitis.
    Landesman SH, Corrado ML, Cherubin CC, Gombert M, Cleri D.
    Am J Med; 1980 Jul; 69(1):92-8. PubMed ID: 6446240
    [Abstract] [Full Text] [Related]

  • 11. Moxalactam therapy for gram-negative bacillary meningitis.
    Rahal JJ.
    Rev Infect Dis; 1982 Jul; 4 Suppl():S606-9. PubMed ID: 6218572
    [Abstract] [Full Text] [Related]

  • 12. In-vitro activity of cefotetan, other beta-lactams and netilmicin.
    Shah PM.
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():73-8. PubMed ID: 6573326
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics and bacteriological effect of ceftazidime in experimental Streptococcus pneumoniae, Haemophilus influenzae, and Escherichia coli meningitis.
    Sakata Y, Boccazzi A, McCracken GH.
    Antimicrob Agents Chemother; 1983 Feb; 23(2):213-7. PubMed ID: 6340600
    [Abstract] [Full Text] [Related]

  • 14. Comparison of netilmicin with gentamicin in the therapy of experimental Escherichia coli meningitis.
    Scheld WM, Brown RS, Sande MA.
    Antimicrob Agents Chemother; 1978 Jun; 13(6):899-904. PubMed ID: 354518
    [Abstract] [Full Text] [Related]

  • 15. In vitro studies of moxalactam (LY127935), a new beta-lactam antibiotic with significant activity against gram-negative bacteria.
    DeMaria A, Alvarez S, Klein JO, McCabe WR.
    Infection; 1980 Jun; 8 Suppl 3():S 261-7. PubMed ID: 6447671
    [Abstract] [Full Text] [Related]

  • 16. The pharmacologic basis for moxalactam therapy for gram-negative enteric bacillary meningitis of infancy.
    McCracken GH, Schaad UB.
    Rev Infect Dis; 1982 Jun; 4 Suppl():S603-5. PubMed ID: 6218571
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli.
    Lang SD, Edwards DJ, Durack DT.
    Antimicrob Agents Chemother; 1980 Mar; 17(3):488-93. PubMed ID: 6252831
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis.
    McCracken GH, Nelson JD, Grimm L.
    Antimicrob Agents Chemother; 1982 Feb; 21(2):262-7. PubMed ID: 6280599
    [Abstract] [Full Text] [Related]

  • 19. New drug evaluations: moxalactam (Moxam, Eli Lilly).
    Polk RE.
    Drug Intell Clin Pharm; 1982 Feb; 16(2):104-12. PubMed ID: 6210519
    [Abstract] [Full Text] [Related]

  • 20. In vitro activities of cefotaxime and moxalactam (LY127935) against Haemophilus influenzae.
    Jorgensen JH, Crawford SA, Alexander GA.
    Antimicrob Agents Chemother; 1980 Mar; 17(3):516-7. PubMed ID: 6252832
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.